Idexx Laboratories (IDXX) EBIAT (2016 - 2025)
Historic EBIAT for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $274.6 million.
- Idexx Laboratories' EBIAT rose 1793.89% to $274.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 1860.76%. This contributed to the annual value of $887.9 million for FY2024, which is 506.78% up from last year.
- Per Idexx Laboratories' latest filing, its EBIAT stood at $274.6 million for Q3 2025, which was up 1793.89% from $294.0 million recorded in Q2 2025.
- Idexx Laboratories' 5-year EBIAT high stood at $294.0 million for Q2 2025, and its period low was $132.0 million during Q2 2022.
- In the last 5 years, Idexx Laboratories' EBIAT had a median value of $204.3 million in 2021 and averaged $208.9 million.
- As far as peak fluctuations go, Idexx Laboratories' EBIAT skyrocketed by 8263.57% in 2021, and later tumbled by 3485.93% in 2022.
- Quarter analysis of 5 years shows Idexx Laboratories' EBIAT stood at $162.8 million in 2021, then increased by 5.8% to $172.2 million in 2022, then grew by 12.96% to $194.5 million in 2023, then increased by 11.12% to $216.1 million in 2024, then increased by 27.05% to $274.6 million in 2025.
- Its EBIAT stands at $274.6 million for Q3 2025, versus $294.0 million for Q2 2025 and $242.7 million for Q1 2025.